Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8410250 Anti-FGFR3 antibodies and methods using same

Patent 8410250 was granted and assigned to Genentech on April, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

84102500

Patent Inventor Names

Avi Ashkenazi0

Yan Wu0

Jing Qing0

Christian Wiesmann0

Date of Patent

April 2, 2013

Patent Application Number

127311000

Date Filed

March 24, 2010

Patent Citations Received

‌

US Patent 11702642 Soluble fibroblast growth factor receptor 3 (FGR3) polypeptide for use in the prevention or treatment of skeletal growth retardation disorders

‌

US Patent 11697678 Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof

‌

US Patent 11654193 Cancer treatment combinations

Patent Primary Examiner

‌

Hong Sang

Patent abstract

The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8410250 Anti-FGFR3 antibodies and methods using same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API